Braintree Laboratories
Clinical trials sponsored by Braintree Laboratories, explained in plain language.
-
New pill aims to heal esophagus damage and keep it healed
Disease control CompletedThis study tested a new medication called BLI5100 in 1250 adults with erosive esophagitis, a condition where stomach acid damages the esophagus. The goal was to see if BLI5100 works better than a standard acid-reducing drug (PPI) at healing the damage within 8 weeks and keeping i…
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated May 17, 2026 13:58 UTC
-
New GERD drug shows safety over one year in 400 patients
Disease control CompletedThis study tested the long-term safety of a daily medication called BLI5100 in 400 adults with gastroesophageal reflux disease (GERD). Participants took the drug once a day for up to 52 weeks. The main goal was to track any side effects. This is not a cure; patients need ongoing …
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated May 15, 2026 11:55 UTC